Pyrogen Testing Market 2022: Industry Size, Share, Growth, Trends and Forecast 2027

According to the latest report by IMARC Group, titled "Pyrogen Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," The global pyrogen testing market reached a value of US$ 1.10 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.04 Billion by 2027, exhibiting at a CAGR of 10.7% during 2022-2027.

Report Metric
Historical: 2016-2021
Base Year: 2021
Forecast Year: 2022-2027

Download free sample of the report: https://www.imarcgroup.com/pyrogen-testing-market/requestsample

Pyrogen Testing Market Industry Definition and Application:

Pyrogen testing is conducted to detect endotoxin and non-endotoxin pyrogenic impurities in aqueous parenteral. It assists in avoiding life-threatening diseases, ensuring the safety of the medical device and parenteral pharmaceutical product, and fatal endotoxic shock induced by substances. Commonly utilized methods of pyrogen testing include the recombinant factor C (RFC) test, limulus amebocyte lysate (LAL) test, rabbit pyrogen test (RPT), and monocyte activation test (MAT). In addition, it is sensitive, robust, and scalable. As a result, pyrogen testing finds widespread applications in healthcare, biologics, and pharmaceuticals across the globe.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Pyrogen Testing Market Trends and Drivers:

The escalating demand for these solutions to safely develop and release infection-free products at a cost-effective price and to determine the presence of metabolites or microbes in drugs during the production process is among the primary factors driving the pyrogen testing market. Besides this, the expanding pharmaceutical and biotechnology industries across the globe and the elevating presence of chronic ailments, such as cancer, heart disease, and diabetes, are further augmenting the market growth. Moreover, the growing popularity of pyrogen testing in the production of COVID-19 vaccines, as it aids in improving the management of infectious illnesses by determining the disease recovery, severity, and sequelae, is also catalyzing the global market. Apart from this, the leading players are introducing cost-effective and technologically advanced techniques that offer a more relevant projection of pyrogenic activity compared to the conventional methods, which is acting as another significant growth-inducing factor. Furthermore, the launch of several policies by the government bodies to fund research and development (R&D) activities to create new therapeutics is anticipated to propel the pyrogen testing market over the forecasted period.

Browse full report with TOC: https://www.imarcgroup.com/pyrogen-testing-market

Pyrogen Testing Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The report has segmented the market on the basis on region, product, test type, application.

Breakup by Product:

Instruments
Kits and Reagents
Services

Breakup by Test Type:

In-vitro Tests
LAL Tests
Rabbit Tests
Others

Breakup by Application:

Pharmaceutical and Biologics
Medical Devices
Others

Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Who are the Major Pyrogen Testing Market Key players?

The report provides a detailed analysis of the market leaders, including.

Charles River Laboratories International Inc., Ellab A/S, Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation), Lonza Group AG, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories LLC (Sotera Health), North American Science Associates Inc., Pacific Biolabs Inc., Sanquin, Thermo Fisher Scientific Inc, Toxikon Corporation and Wuxi Apptec.

Related Report by IMARC Group:

Pen Needles Market Report: https://www.imarcgroup.com/pen-needles-market

Biosurgery Market Report: https://www.imarcgroup.com/biosurgery-market

United States Insulin Pumps Market Report: https://www.imarcgroup.com/united-states-insulin-pumps-market

Recombinant DNA Technology Market Report: https://www.imarcgroup.com/recombinant-dna-technology-market

Protein Purification and Isolation Market Report: https://www.imarcgroup.com/protein-purification-isolation-market

Drug Abuse Testing Market Report: https://www.imarcgroup.com/drug-abuse-testing-market

Latin America Generic Injectables Market Report: https://www.imarcgroup.com/latin-america-generic-injectables-market

India Generic Injectables Market Report: https://www.imarcgroup.com/india-generic-injectables-market

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.